SCHEMBL8900244

SCHEMBL8900244

C/N=C(\C)c1ccc2nc(N[RaH])ccc2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
CCR6 P51684 2/20 0.33
CYP3A4 P08684 2/20 0.33
MAPT P10636 1/20 0.33
MTOR P42345 1/20 0.33
CXCR5 P32302 1/20 0.33
APLNR P35414 1/20 0.33
LRRK2 Q5S007 1/20 0.33
PLK1 P53350 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PAX8 Q06710 1/20 0.33
MTTP P55157 2/20 0.32
NCF1 P14598 1/20 0.32
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8901370 0.81 CYP2A6 (0.45) NPC1RAB9AMAPTMTORPLK1
SCHEMBL8899884 0.74 MTOR (0.34) NPC1RAB9AMTORPLK1
SCHEMBL8900693 0.70 HTR3A (0.42) NPC1RAB9AMAPTSMN1; SMN2HTT
SCHEMBL8902362 0.69 EGFR (0.45) NPC1RAB9AMAPTTP53NCF1
SCHEMBL8900732 0.68 PLAU (0.57) CYP3A4MAPTTP53SMN1; SMN2ALOX15
SCHEMBL8901397 0.68 BACE1 (0.53) NPC1RAB9AMAPTCYP1A2CYP2D6
SCHEMBL8902299 0.67 MAPT (0.47) NPC1RAB9AMAPTSMN1; SMN2HTT
SCHEMBL8902031 0.66 MAPT (0.37) NPC1RAB9ACYP3A4MAPTCYP1A2
SCHEMBL8900141 0.65 KDM4E (0.44) NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL2671343 0.65 HCAR3 (0.54) NPC1RAB9AMAPTPLK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227583-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2B NPC1 2445/4885RAB9A 177/4885CCR6 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.